IE
VOR icon

Israel Englander’s Vor Biopharma VOR Stock Holding History

Israel Englander’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.88M Buy
428,067
+169,480
+66% +$2.56M ﹤0.01% 2547
2026
Q1 		$4.61M Buy
258,587
+34,053
+15% +$480K ﹤0.01% 3039
2025
Q4 		$2.94M Buy
224,534
+199,770
+807% +$3.72M ﹤0.01% 3582
2025
Q3 		$1.21M Buy
+24,764
New +$996K ﹤0.01% 4482
2025
Q2 		– Sell
-9,342
Closed -$82.6K – 6363
2025
Q1 		$134K Sell
9,342
-3,750
-29% -$90K ﹤0.01% 5387
2024
Q4 		$291K Sell
13,092
-2,099
-14% -$34.8K ﹤0.01% 5089
2024
Q3 		$213K Sell
15,191
-4,291
-22% -$78.2K ﹤0.01% 5415
2024
Q2 		$390K Buy
19,482
+11,562
+146% +$374K ﹤0.01% 4751
2024
Q1 		$375K Buy
+7,920
New +$348K ﹤0.01% 4996
2023
Q3 		– Sell
-3,135
Closed -$194K – 6612
2023
Q2 		$194K Sell
3,135
-17,208
-85% -$1.57M ﹤0.01% 5130
2023
Q1 		$2.19M Sell
20,343
-4,561
-18% -$506K ﹤0.01% 3358
2022
Q4 		$3.31M Buy
24,904
+7,958
+47% +$787K ﹤0.01% 3131
2022
Q3 		$1.35M Buy
16,946
+2,499
+17% +$246K ﹤0.01% 4090
2022
Q2 		$1.44M Buy
14,447
+13,616
+1,639% +$1.39M ﹤0.01% 4034
2022
Q1 		$100K Buy
+831
New +$141K ﹤0.01% 6152
2021
Q3 		– Sell
-917
Closed -$342K – 7292
2021
Q2 		$342K Buy
+917
New +$452K ﹤0.01% 5637

Other funds holding VOR

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Israel Englander's VOR Position: Q2 2026 in Review

Israel Englander increased its Vor Biopharma (VOR) stake by 66% in Q2 2026, buying an estimated $2.56M and bringing the position to 428,067 shares worth $7.88M. The position accounts for ﹤0.01% of the portfolio, ranked #2547.

Israel Englander first reported a position in VOR in Q2 2021 and has held it in 16 quarters since. 102 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

  • Israel Englander held 428,067 shares of Vor Biopharma worth $7.88M as of Q2 2026.
  • Israel Englander bought 169,480 Vor Biopharma shares in Q2 2026, an estimated $2.56M.
  • Vor Biopharma made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2547 holding.
  • Israel Englander first reported a position in Vor Biopharma in Q2 2021 and has held it in 16 quarters since.
  • 102 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.